Thomas Dugan

Thomas Dugan

Plus aucun poste en cours

Fortune : 79 356 $ au 31/05/2026

68 ans
Health Technology
Electronic Technology
Health Services

Profil

Thomas J.
Dugan
served as Chief Executive Officer & Director at Biotissue Surgical, Inc. Held the position of Chairman at BioStem Technologies, Inc. from 2023 to 2026.
Acted as Director at RITA Medical Systems, Inc. in 2004.
Worked as Vice President-Business Development at Datascope Corp.
from 2001 to 2004.
Occupied the role of Vice President-Marketing at United States Surgical Corp.
from 1996 to 2001.
Served as Senior Vice President-Global Marketing & US Sales at FUJIFILM SonoSite, Inc. from 2005 to 2008.
Held the title of President-North American Business at Smith & Nephew plc.
Was President & Chief Commercialization Officer at SurgiQuest, Inc. from 2013 to 2014.
Served as President at InterVascular, Inc. from 2002 to 2004.
Worked as President-US at Integrum AB from 2021 to 2023.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/09/2025 19 168 ( 0,12 % ) 79 356 $ 31/05/2026

Anciens postes connus de Thomas Dugan

SociétésPosteFin
BIOSTEM TECHNOLOGIES, INC. Président -
INTEGRUM AB Corporate Officer/Principal 03/07/2023
Sales & Marketing 11/09/2008
Directeur/Membre du Conseil 05/11/2004
Corporate Officer/Principal 01/01/2004
Voir l'expérience en détail de Thomas Dugan

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

37

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

  1. Bourse
  2. Insiders
  3. Thomas Dugan
🔇